Skip to main content
Journal of Clinical Pathology logoLink to Journal of Clinical Pathology
. 1999 Jul;52(7):494–497. doi: 10.1136/jcp.52.7.494

Is the international normalised ratio (INR) reliable? A trial of comparative measurements in hospital laboratory and primary care settings.

F D Hobbs 1, D A Fitzmaurice 1, E T Murray 1, R Holder 1, P E Rose 1, J L Roper 1
PMCID: PMC501488  PMID: 10605400

Abstract

AIM: To determine the reliability of international normalised ratio (INR) measurement in primary care by practice nurses using near patient testing (NPT), in comparison with results obtained within hospital laboratories by varied methods. METHODS: As part of an MRC funded study into primary care oral anticoagulation management, INR measurements obtained in general practice were validated against values on the same samples obtained in hospital laboratories. A prospective comparative trial was undertaken between three hospital laboratories and nine general practices. All patients attending general practice based anticoagulant clinics had parallel INR estimations performed in general practice and in a hospital laboratory. RESULTS: 405 tests were performed. Comparison between results obtained in the practices and those in the reference hospital laboratory (gold standard), which used the same method of testing for INR, showed a correlation coefficient of 0.96. Correlation coefficients comparing the results with the various standard laboratory techniques ranged from 0.86 to 0.92. It was estimated that up to 53% of tests would have resulted in clinically significant differences (change in warfarin dose) depending upon the site and method of testing. The practice derived results showed a positive bias ranging from 0.28 to 1.55, depending upon the site and method of testing. CONCLUSIONS: No technical problems associated with INR testing within primary care were uncovered. Discrepant INR results are as problematic in hospital settings as they are in primary care. These data highlight the failings of the INR to standardise when different techniques and reagents are used, an issue which needs to be resolved. For primary care to become more involved in therapeutic oral anticoagulation monitoring, close links are needed between hospital laboratories and practices, particularly with regard to training and quality assurance.

Full text

PDF
494

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Eckman M. H., Levine H. J., Pauker S. G. Effect of laboratory variation in the prothrombin-time ratio on the results of oral anticoagulant therapy. N Engl J Med. 1993 Sep 2;329(10):696–702. doi: 10.1056/NEJM199309023291005. [DOI] [PubMed] [Google Scholar]
  2. Hirsh J., Poller L. The international normalized ratio. A guide to understanding and correcting its problems. Arch Intern Med. 1994 Feb 14;154(3):282–288. doi: 10.1001/archinte.154.3.282. [DOI] [PubMed] [Google Scholar]
  3. Kapiotis S., Quehenberger P., Speiser W. Evaluation of the new method Coaguchek for the determination of prothrombin time from capillary blood: comparison with Thrombotest on KC-1. Thromb Res. 1995 Mar 15;77(6):563–567. doi: 10.1016/0049-3848(95)00031-3. [DOI] [PubMed] [Google Scholar]
  4. Lassen J. F., Brandslund I., Antonsen S. International normalized ratio for prothrombin times in patients taking oral anticoagulants: critical difference and probability of significant change in consecutive measurements. Clin Chem. 1995 Mar;41(3):444–447. [PubMed] [Google Scholar]
  5. Morrison M., Caldwell A., McQuaker G., Fitzsimons E. J. Discrepant INR values: a comparison between Manchester and Thrombotest reagents using capillary and venous samples. Clin Lab Haematol. 1989;11(4):393–398. doi: 10.1111/j.1365-2257.1989.tb00238.x. [DOI] [PubMed] [Google Scholar]
  6. Morrison M., Fitzsimons E. J. Discrepant INR values strike again. Clin Lab Haematol. 1991;13(2):221–222. doi: 10.1111/j.1365-2257.1991.tb00273.x. [DOI] [PubMed] [Google Scholar]
  7. Poller L., Taberner D. A. Dosage and control of oral anticoagulants: an international collaborative survey. Br J Haematol. 1982 Jul;51(3):479–485. doi: 10.1111/j.1365-2141.1982.tb02805.x. [DOI] [PubMed] [Google Scholar]
  8. Poller L., Taberner D. A. Dosage and control of oral anticoagulants: an international collaborative survey. Br J Haematol. 1982 Jul;51(3):479–485. doi: 10.1111/j.1365-2141.1982.tb02805.x. [DOI] [PubMed] [Google Scholar]
  9. Preston F. E. Quality control and oral anticoagulation. Thromb Haemost. 1995 Jul;74(1):515–520. [PubMed] [Google Scholar]
  10. Sweeney K. G., Gray D. P., Steele R., Evans P. Use of warfarin in non-rheumatic atrial fibrillation: a commentary from general practice. Br J Gen Pract. 1995 Mar;45(392):153–158. [PMC free article] [PubMed] [Google Scholar]
  11. Taylor F., Ramsay M., Voke J., Cohen H. Anticoagulation in patients with atrial fibrillation. GPs not prepared for monitoring anticoagulation. BMJ. 1993 Dec 4;307(6917):1493–1493. doi: 10.1136/bmj.307.6917.1493. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Journal of Clinical Pathology are provided here courtesy of BMJ Publishing Group

RESOURCES